Wall Street Associates’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.12M Sell
43,740
-208
-0.5% -$5.46K 0.74% 51
2016
Q3
$1.2M Hold
43,948
0.41% 95
2016
Q2
$1.24M Buy
43,948
+1,080
+3% +$27.8K 0.5% 79
2016
Q1
$1.01M Sell
42,868
-45,416
-51% -$1M 0.42% 94
2015
Q4
$1.99M Sell
88,284
-4,680
-5% -$107K 0.56% 57
2015
Q3
$2.15M Sell
92,964
-24,704
-21% -$619K 0.41% 79
2015
Q2
$2.9M Buy
117,668
+46,196
+65% +$1.15M 0.27% 109
2015
Q1
$1.79M Buy
71,472
+22,208
+45% +$528K 0.17% 153
2014
Q4
$1.14M Buy
49,264
+19,008
+63% +$435K 0.11% 192
2014
Q3
$708K Sell
30,256
-3,680
-11% -$86.3K 0.07% 222
2014
Q2
$785K Buy
+33,936
New +$750K 0.07% 229

Other funds holding TECH

Wall Street Associates's TECH Position: Q4 2016 in Review

Wall Street Associates reduced its Bio-Techne (TECH) stake by 0.47% in Q4 2016, selling an estimated $5.46K and leaving 43,740 shares worth $1.12M. The position accounts for 0.74% of the portfolio, ranked #51.

Wall Street Associates first reported a position in TECH in Q2 2014 and has held it in 11 quarters since. The position peaked at $2.9M in Q2 2015. 281 funds tracked by Wall St. Rank hold TECH as of Q4 2016.

  • Wall Street Associates held 43,740 shares of Bio-Techne worth $1.12M as of Q4 2016.
  • Wall Street Associates sold 208 Bio-Techne shares in Q4 2016, an estimated $5.46K.
  • Bio-Techne made up 0.74% of Wall Street Associates's portfolio in Q4 2016, its #51 holding.
  • Wall Street Associates first reported a position in Bio-Techne in Q2 2014 and has held it in 11 quarters since.
  • Wall Street Associates's Bio-Techne position peaked at $2.9M in Q2 2015.
  • 281 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2016.

Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.